Burning rock announces plan to pursue an alternative listing

Guangzhou, china, june 21, 2022 (globe newswire) -- burning rock biotech limited (nasdaq: bnr, the “company” or “burning rock”), a company focused on the application of next generation sequencing (ngs) technology in the field of precision oncology, today announced that the board of directors of the company (the “board”) approved a motion to pursue an alternative listing of the company's class a ordinary shares on an internationally recognized stock exchange. the alternative listing is expected to offer fungibility with the company's american depositary shares (“adss”) that are currently listed on nasdaq, in order to ensure continued and seamless trading for shareholders amid an evolving market and regulatory environment. the board also authorized the company's senior management to engage relevant professional parties, proceed with the relevant preparatory work and undertake the necessary procedures with respect to the alternative listing.
BNR Ratings Summary
BNR Quant Ranking